Darren McGuire, MD, Cardiology, Dallas, TX, University of Texas Southwestern Medical Center

DarrenKeithMcGuireMD

Cardiology Dallas, TX

Distinguished Teaching Professor, Internal Medicine, Dallas Heart Ball Chair for Heart Disease Research in Women, University of Texas Southwestern Medical Center, Deputy Editor, Circulation

Dr. McGuire is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McGuire's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 1997 - 2001
  • Duke University School of MedicineM.H.S., Clinical Research Training Program, 1998 - 2000
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1993 - 1996
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1993
  • Hendrix CollegeB.A., Chemistry, Summa Cum Laude, 1985 - 1989

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1996 - 2002
  • TX State Medical License
    TX State Medical License 1994 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FAHA) AHA
  • Fellow (FESC) European Society of Cardiology
  • Regents Outstanding Teacher Award University of Texas Board of Regents, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults with Diabetes  
    Michael C Honigberg, Ravi B Patel, Javed Butler, Darren K Mcguire, JAMA Cardiology
  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure  
    Deepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
  • Association of SGLT2 Inhibitors with Cardiovascular and Kidney Outcomes in Patients with Type 2 Diabetes  
    Darren K Mcguire, Samuel Dagogo-Jack, Urszula Masiukiewicz, JAMA Cardiology
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • A1C : Glucose management in type 2 diabetes mellitus.
    Goyal A, Kosiborod M, McGuire DK, Garber AJ, American College of Cardiology Foundation Diabetes Self-Assessment Program, Washington, DC, 1/1/2011

Lectures

  • Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
    Scientific Sessions 2008, New Orleans, Louisiana, USA
  • Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
    Scientific Sessions 2007, Orlando, Florida, USA
  • Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
    International Chair on Cardiometabolic Risk, 2nd International Congress on Abdominal Obesity, Buenos
  • Join now to see all

Other

Authored Content

  • Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular DiseaseJune 2020
  • Heart Failure Epidemiology in Patients with Diabetes Mellitus Without Coronary Heart DiseaseNovember 2018
  • Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients with Type 2 DiabetesMarch 2018

Press Mentions

  • Postcard from the Pandemic: A Cardiologist at UT Southwestern and Parkland Talks Lessons Learned on the Frontline of the Coronavirus
    Postcard from the Pandemic: A Cardiologist at UT Southwestern and Parkland Talks Lessons Learned on the Frontline of the CoronavirusApril 14th, 2020
  • DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF
    DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEFSeptember 16th, 2019
  • DAPA-HF Details: Dapagliflozin Deletes HF Results, Even in Nondiabetics
    DAPA-HF Details: Dapagliflozin Deletes HF Results, Even in NondiabeticsSeptember 2nd, 2019
  • Join now to see all

Grant Support

  • Rosiglitazone VS Placebo: Effect Of CV Performance And Myocardial TriglycerideNational Center For Research Resources2005–2007

Professional Memberships

Hospital Affiliations